Biogen, Inc. (BIIB)
$265.12 0.35 (0.13%)
19:59 EDT BIIB Stock Quote Delayed 30 Minutes
Previous Close $265.12
Market Cap 55.94B
PE Ratio 18.94
Volume (Avg. Vol.) 943,000
Day's Range 264.12 - 267.98
52-Week Range 215.77 - 374.99
Dividend & Yield N/A (N/A)
BIIB Stock Predictions, Articles, and Biogen, Inc. News
- From InvestorPlace
- From the Web
Biogen (BIIB) news for Thursday concerning a lost court ruling surrounding its multiple sclerosis drug has BIIB stock taking a beating.
Biogen has solid and consistent revenue, profit and cash flow. But Biogen stock has a low valuation because it has no growth.
Investors need to differentiate between speculative stocks rising higher than ever and proven blue-chip stocks, and stick to the latter.
Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.
The Alzheimer's-drug delay disappointed Biogen stock owners, but the long-term outlook for the company remains solid.
Investors are often wrong about how they trade mega cap stocks on their earnings headline. This created opportunities in INTC, IBM and BIIB.
Thursday's big stock charts feature names that released noteworthy earnings data.
Thursday's big stock charts feature names that outperformed during a major market surge.
Tuesday's big stock charts feature stocks holding support whose businesses could, and maybe should, hold up in the near term.
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.
By Ian Cooper
One of the best ways to profit is to invest like Warren Buffett. Here are three Berkshire Hathaway stocks that he's watching now.
Ford and Disney sank on earnings, while oil demand could shrivel up in China. Here's what happened in the stock market today.
Wednesday's big stock charts highlight 3 stocks looking to break through resistance in a market that looks a bit shaky at the moment.
Value stocks are hot these days, and the best part is the shift toward them isn't stopping anytime soon. Here are five to buy today.
RH, Dollar General, Kroger, Biogen and Signet Jewelers were our top stock trades for Friday. Let's look at the charts.
With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.
With news that Biogen’s Alzheimer’s drug was allowed to reapply for possible FDA approval, Biogen stock skyrocketed. However, investors will want to carefully consider all angles before jumping onboard.
This morning, I'm recommending a bullish call option on Aimmune Therapeutics, Inc. (NASDAQ:AIMT), the biopharmaceutical company.
From The Motley Fool
From Market News Video
Investors in Johnson Controls International plc (JCI) saw new options become available today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the JCI options chain for the new August 14th contracts and identified one put and one call contract of particular interest.
From Market News Video
Investors in Johnson Controls International plc (JCI) saw new options become available today, for the August 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the JCI options chain for the new August 7th contracts and identified one put and one call contract of particular interest.
Navellier RatingsPowered by Portfolio Grader